Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

2.

Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.

Delea TE, Hagiwara M, Stanford RH, Stempel DA.

Clin Ther. 2008 Mar;30(3):560-71. doi: 10.1016/j.clinthera.2008.03.011.

PMID:
18405796
3.

Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.

Stanford RH, Blanchette CM, Roberts MH, Petersen H, Fuhlbrigge AL.

Am J Geriatr Pharmacother. 2012 Dec;10(6):343-51. doi: 10.1016/j.amjopharm.2012.09.005. Epub 2012 Oct 17.

PMID:
23083688
4.

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455.

5.

Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.

Hagiwara M, Delea TE, Stanford RH.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):54-62. doi: 10.2500/aap.2014.35.3720.

PMID:
24433597
6.
7.

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.

Delea TE, Stanford RH, Hagiwara M, Stempel DA.

Curr Med Res Opin. 2008 Dec;24(12):3435-42. doi: 10.1185/03007990802557344 .

PMID:
19032125
8.

Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.

Hagiwara M, Delea TE, Stanford RH, Stempel DA.

Allergy Asthma Proc. 2010 May-Jun;31(3):203-10. doi: 10.2500/aap.2010.31.3359.

PMID:
20534183
9.

Retrospective comparison of early versus late treatment with fluticasone propionate/salmeterol after an asthma exacerbation.

Hagiwara M, Delea TE, Stanford RH.

J Asthma. 2011 Sep;48(7):721-8. doi: 10.3109/02770903.2011.599908. Epub 2011 Jul 28.

PMID:
21793768
10.

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Delea TE, Hagiwara M, Dalal AA, Stanford RH, Blanchette CM.

Curr Med Res Opin. 2009 Jan;25(1):1-13. doi: 10.1185/03007990802534020 .

PMID:
19210134
11.

Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges.

Navaratnam P, Friedman HS, Urdaneta E.

Curr Med Res Opin. 2009 Dec;25(12):2895-901. doi: 10.1185/03007990903336515.

PMID:
19821655
12.
14.

Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.

Tunceli O, Williams SA, Kern DM, Elhefni H, Pethick N, Wessman C, Zhou S, Trudo F.

J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):719-26. doi: 10.1016/j.jaip.2014.07.016. Epub 2014 Oct 3.

16.

Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.

Navaratnam P, Friedman HS, Urdaneta E.

Value Health. 2011 Mar-Apr;14(2):339-46. doi: 10.1016/j.jval.2011.01.001.

18.

Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.

Vogelmeier C, Naya I, Ekelund J.

Clin Drug Investig. 2012 Jul 1;32(7):439-49. doi: 10.2165/11598840-000000000-00000.

PMID:
22607479
20.

Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.

Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.

Clin Ther. 2009 May;31(5):1056-63. doi: 10.1016/j.clinthera.2009.05.008.

PMID:
19539106

Supplemental Content

Support Center